von willebrand factor
SpainDrugs containing this active substance
-
It is used for the treatment and prevention of bleeding in people with hemophilia A (factor VIII deficiency) and for the treatment of bleeding or surgical bleeding in patients with von Willebrand disease, especially when other treatments are not effective.
Form: powder and solvent for solution for injection
Active substance Dosage factor viii 100 UI von willebrand factor 120 UI Manufacturer: Instituto Grifols S.A.
-
It is used for the treatment and prevention of bleeding in people with Hemophilia A. It is also used to treat bleeding and prevent bleeding during surgery in patients with von Willebrand disease, especially when other treatments are not effective.
Form: powder and solvent for solution for injection
Active substance Dosage factor viii 250 UI von willebrand factor 300 UI Manufacturer: Instituto Grifols S.A.
-
It is used for the treatment and prevention of bleeding in people with hemophilia A (factor VIII deficiency) and for the treatment of bleeding and prevention of surgical bleeding in patients with von Willebrand disease, when other treatments are not effective or cannot be used.
Form: powder and solvent for solution for injection
Active substance Dosage factor viii 500 UI von willebrand factor 600 UI Manufacturer: Instituto Grifols S.A.
-
It is used for the treatment and prevention of bleeding in individuals with von Willebrand disease or hemophilia A. It may also be useful in cases of acquired factor VIII deficiency.
Form: powder and solvent for solution for injection and for infusion
Active substance Dosage factor viii 500 UI von willebrand factor 1200 UI Manufacturer: Csl Behring S.A.
-
It is used for the treatment and prevention of bleeding in people with hemophilia A or von Willebrand disease. It may also be useful in cases of acquired factor VIII deficiency.
Form: powder and solvent for solution for injection and for infusion
Active substance Dosage factor viii 1000 UI von willebrand factor 2400 UI Manufacturer: Csl Behring S.A.